Harbor Capital Advisors, Inc. Ironwood Pharmaceuticals Inc Transaction History
Harbor Capital Advisors, Inc.
- $1.31 Billion
- Q2 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 111,974 shares of IRWD stock, worth $450,135. This represents 0.06% of its overall portfolio holdings.
Number of Shares
111,974
Previous 55,857
100.47%
Holding current value
$450,135
Previous $487,000
49.9%
% of portfolio
0.06%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding IRWD
# of Institutions
247Shares Held
171MCall Options Held
11.2MPut Options Held
28.5K-
Black Rock Inc. New York, NY22.9MShares$92 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$86.7 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$65.9 Million18.04% of portfolio
-
State Street Corp Boston, MA9.24MShares$37.2 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA8.91MShares$35.8 Million0.15% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $616M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...